[National consensus on the modified Atkins diet].

Introduction: Epilepsy is a chronic disease that affects 0.5-1% of the population. One third of the patients become refractory to antiepileptic drugs.

Recommendations for the clinical management of children with refractory epilepsy receiving the ketogenic diet.

The ketogenic diet, a non-drug treatment with proven effectiveness, has been the most commonly used therapy in the past decade for the management of refractory epilepsy in the pediatric population. Compared to adding a new drug to a pre-existing treatment, the ketogenic diet is highly effective and reduces the number of seizures by 50-90% in approximately 45-60% of children after six months of treatment. For this reason, the Argentine Society of Pediatric Neurology established the Ketogenic Diet Working Group.

Ketogenic diet in patients with epileptic encephalopathy with electrical status epilepticus during slow sleep.

Unlabelled: Epileptic encephalopathy with electrical status epilepticus during slow sleep (ESES) belongs to the group of epileptic encephalopathies that often prove refractory to AED treatment. The ketogenic diet (KD) has been used as an alternative to antiepileptic drugs (AEDs) for patients with refractory epileptic encephalopathies.

Purpose: In this retrospective study we assess the efficacy and tolerability of the KD in patients with ESES syndrome.

Ketogenic diet in pediatric patients with refractory focal status epilepticus.

Unlabelled: The ketogenic diet (KD) has been used as an alternative treatment for patients with refractory status epilepticus (SE).

Purpose: In this retrospective study we assess the efficacy and tolerability of the KD in patients with refractory SE.

Methods: Between March 1, 2010 and January 1, 2014, 10 patients who met the diagnostic criteria of refractory SE seen at our department were placed on the KD and followed for a minimum of 6 months.

Ketogenic diet in patients with Lennox-Gastaut syndrome.

Purpose: The ketogenic diet (KD) has been used as an alternative to antiepileptic drugs (AEDs) for patients with refractory epilepsy. Lennox-Gastaut syndrome (LGS) belongs to the group of epileptic encephalopathies that often prove refractory to AED treatment. In this prospective study we assess the efficacy and tolerability of the KD in patients with LGS.